Alessandra Bosch: Von Willebrand Disease and Rare Bleeding Disorders, Collaborative Insights and Patient Empowerment
Alessandra Bosch, Clinician Scientist at University of Zurich, shared a post on LinkedIn:
“Such an inspiring Saturday at the Von Willebrand Disease and Rare Bleeding Disorders Patient Day (SHG) in Bern a full day dedicated to von Willebrand disease and rare bleeding disorder patients, held in German and French with simultaneous translation.
It was great to share the stage with colleagues AlessandroCasini (HUG) on new treatments and therapies for rare bleeding disorders, and Sebastien L. (HUG, UCLouvain) on the role of physiotherapy and joint assessment in Von Willebrand disease, including a hands on ultrasound workshop.
I had the pleasure of presenting on bleeding symptoms in women and girls with bleeding disorders, and giving a workshop on heavy menstrual bleeding in adolescents young women.
Thank you to the Schweizerische Hämophilie Gesellschaft for organizing such a valuable event for the bleeding disorders community.
And a big THANKS to the patients for your active participation!”
Stay updated with Hemostasis Today.
-
Sep 8, 2026, 15:34Ron DePinho: A Negative Trial Highlights the Need for Precision in Cardiovascular Inflammation
-
Sep 8, 2026, 15:31Adil Yousaf: Thrombolysis Speed Matters, but Eligibility Comes First
-
Sep 8, 2026, 15:28Dhargam Aljebouri: First Molecularly Characterized Para-Bombay Phenotype in the Arab World
-
Sep 8, 2026, 15:27Mohd Ashhad: How Much Does Hemoglobin Increase After 1 Unit of PRBC?
-
Sep 8, 2026, 15:27Sanish Babu: The Hematocrit–Platelet Signal in Severe Dengue
-
Sep 8, 2026, 15:26Mary Kama: Climate-Informed Early Warning Systems for Sickle Cell Anaemia
-
Sep 8, 2026, 15:23Marissa Lechuga: Digital Transformation in Healthcare for People Living With SCD
-
Sep 8, 2026, 15:21Mohammed Javad Yousefi: Iron Deficiency and Anaemia Among Adolescent Girls in Iran
-
Sep 8, 2026, 15:21ISTH 2026 Highlights, Expert Insights Into Thrombosis and Hemostasis – RFHT